Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.verified

VVY.AS

Price:

$1.61

Market Cap:

$41.97M

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a small molecule QC inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease; and for the treatment of cancer. Its preclinical development product is PQ1565, a small molecule glutaminyl-peptide cyclotransferase-like inhibitor for the treatment of cancer. In addition, the company is developing a monoclonal antibody...[Read more]

Industry

Biotechnology

IPO Date

2014-10-27

Stock Exchange

AMS

Ticker

VVY.AS

The ROE as of December 2025 (TTM) for Vivoryon Therapeutics N.V. (VVY.AS) is -225.69%

According to Vivoryon Therapeutics N.V.’s latest financial reports and current stock price. The company's current ROE is -225.69%. This represents a change of 112.39% compared to the average of -106.26% of the last 4 quarters.

Vivoryon Therapeutics N.V. (VVY.AS) Historical ROE (quarterly & annually)

How has VVY.AS ROE performed in the past?

The mean historical ROE of Vivoryon Therapeutics N.V. over the last ten years is -88794.98%. The current -225.69% ROE has changed -99.75% with respect to the historical average. Over the past ten years (40 quarters), VVY.AS's ROE was at its highest in in the June 2014 quarter at 47.13%. The ROE was at its lowest in in the December 2018 quarter at -294065.04%.

Quarterly (TTM)
Annual

Average

-88794.98%

Median

-184.43%

Minimum

-629024.39%

Maximum

-18.34%

Vivoryon Therapeutics N.V. (VVY.AS) ROE by Quarter and Year

Discovering the peaks and valleys of Vivoryon Therapeutics N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 600.81%

Maximum Annual ROE = -18.34%

Minimum Annual Increase = -100.00%

Minimum Annual ROE = -629024.39%

Quarterly (TTM)
Annual
YearROEChange
2024-261.02%142.04%
2023-107.84%1.52%
2022-106.23%38.98%
2021-76.43%21.39%
2020-62.96%243.40%
2019-18.34%-100.00%
2018-629024.39%600.81%
2017-89756.81%5.81%
2016-84825.35%1.33%
2015-83710.41%16.90%

Vivoryon Therapeutics N.V. (VVY.AS) Average ROE

How has VVY.AS ROE performed in the past?

The current ROE of Vivoryon Therapeutics N.V. (VVY.AS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-158.36%

5-year avg

-122.90%

10-year avg

-88794.98%

Vivoryon Therapeutics N.V. (VVY.AS) ROE vs. Peers

How is VVY.AS’s ROE compared to its peers?

Vivoryon Therapeutics N.V.’s ROE is greater than Avantium N.V. (-26.48%), less than B&S Group S.A. (22.11%), greater than Marinomed Biotech AG (-103.28%), less than Pharming Group N.V. (0.16%), greater than Ryvu Therapeutics S.A. (-89.88%),

Build a custom stock screener for Vivoryon Therapeutics N.V. (VVY.AS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivoryon Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vivoryon Therapeutics N.V. (VVY.AS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vivoryon Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Vivoryon Therapeutics N.V.'s ROE?

How is the ROE calculated for Vivoryon Therapeutics N.V. (VVY.AS)?

What is the highest ROE for Vivoryon Therapeutics N.V. (VVY.AS)?

What is the 3-year average ROE for Vivoryon Therapeutics N.V. (VVY.AS)?

What is the 5-year average ROE for Vivoryon Therapeutics N.V. (VVY.AS)?

How does the current ROE for Vivoryon Therapeutics N.V. (VVY.AS) compare to its historical average?